-transparent.png){kind=logo}
A review is presented of experimental information pertaining to the characteristics of a procedure designed to quantitate the capacity for self-renewal in clonogenic cells of human acute myeloblastic leukemia. In a series of 44 previously untreated patients, a significant correlation (p less than 0.01) was seen between low capacity for self-renewal and successful remission induction. Three cytotoxic drugs (Adriamycin, 1-beta-D-arabinofuranosylcytosine, and N-[4-(19-acridinylamino)-3-methoxyphenyl]-methanesulfonamide) were tested for preferential effect against self-renewal events. Surviving clonogenic cells to these agents had, respectively, unchanged, lower, and higher capacity for self-renewal. The implications of such drug properties are discussed.
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
January 1991,
Leukemia,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
July 1979,
Blood,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
May 2004,
Blood,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
September 2012,
Cell cycle (Georgetown, Tex.),
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
July 2008,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
March 2020,
Epigenomes,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
January 1982,
Journal of cellular physiology. Supplement,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
August 1993,
International journal of oncology,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
January 1980,
Progress in clinical and biological research,
R N Buick, and
L J Chang, and
H A Messner, and
J E Curtis, and
E A McCulloch
April 2024,
Biochemical and biophysical research communications,
